AAV vectors: The Rubik's cube of human gene therapy
A Pupo, A Fernández, SH Low, A François… - Molecular Therapy, 2022 - cell.com
Defective genes account for∼ 80% of the total of more than 7,000 diseases known to date.
Gene therapy brings the promise of a one-time treatment option that will fix the errors in …
Gene therapy brings the promise of a one-time treatment option that will fix the errors in …
Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles
A large body of evidence indicates that mitochondrial dysfunction has a major role in the
pathogenesis of multiple cardiovascular disorders. Over the past 2 decades, extraordinary …
pathogenesis of multiple cardiovascular disorders. Over the past 2 decades, extraordinary …
Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells
G Liang, S Kan, Y Zhu, S Feng, W Feng… - International journal of …, 2018 - Taylor & Francis
Introduction Exosomes are closed-membrane nanovesicles that are secreted by a variety of
cells and exist in most body fluids. Recent studies have demonstrated the potential of …
cells and exist in most body fluids. Recent studies have demonstrated the potential of …
In vivo genome editing restores dystrophin expression and cardiac function in dystrophic mice
Rationale: Duchenne muscular dystrophy is a severe inherited form of muscular dystrophy
caused by mutations in the reading frame of the dystrophin gene disrupting its protein …
caused by mutations in the reading frame of the dystrophin gene disrupting its protein …
The heterocellular heart: identities, interactions, and implications for cardiology
The heterocellular nature of the heart has been receiving increasing attention in recent
years. In addition to cardiomyocytes as the prototypical cell type of the heart, non-myocytes …
years. In addition to cardiomyocytes as the prototypical cell type of the heart, non-myocytes …
[HTML][HTML] The roles of lncRNA in myocardial infarction: molecular mechanisms, diagnosis biomarkers, and therapeutic perspectives
L Xie, Q Zhang, J Mao, J Zhang, L Li - Frontiers in cell and …, 2021 - frontiersin.org
In recent years, long non-coding RNAs (lncRNAs) have been demonstrated to be associated
with many physiological and pathological processes in cardiac. Recent studies have shown …
with many physiological and pathological processes in cardiac. Recent studies have shown …
Mitochondrial dysfunction in cardiovascular disease: Current status of translational research/clinical and therapeutic implications
AS Manolis, AA Manolis, TA Manolis… - Medicinal Research …, 2021 - Wiley Online Library
Mitochondria provide energy to the cell during aerobic respiration by supplying~ 95% of the
adenosine triphosphate (ATP) molecules via oxidative phosphorylation. These organelles …
adenosine triphosphate (ATP) molecules via oxidative phosphorylation. These organelles …
Calcium dysregulation in heart diseases: Targeting calcium channels to achieve a correct calcium homeostasis
Intracellular calcium signaling is a universal language source shared by the most part of
biological entities inside cells that, all together, give rise to physiological and functional …
biological entities inside cells that, all together, give rise to physiological and functional …
[HTML][HTML] Metal-based nanoparticles: Promising tools for the management of cardiovascular diseases
NK Younis, JA Ghoubaira, EP Bassil… - … , Biology and Medicine, 2021 - Elsevier
Cardiovascular disease (CVD) is the leading cause of death worldwide. A search for more
effective treatments of CVD is increasingly needed. Major advances in nanotechnology …
effective treatments of CVD is increasingly needed. Major advances in nanotechnology …
Gene therapy for ischaemic heart disease and heart failure
H Korpela, N Järveläinen, S Siimes… - Journal of Internal …, 2021 - Wiley Online Library
Gene therapy has been expected to become a novel treatment method since the structure of
DNA was discovered in 1953. The morbidity from cardiovascular diseases remains …
DNA was discovered in 1953. The morbidity from cardiovascular diseases remains …